diseases have been implicated in the development of intrinsic asthma, however little data are available on the role of autoimmunity in the pathogenesis of asthma. The purpose of this study was to investigate circulating autoantibodies against the high-affinity receptor for immunoglobulin E, FcεRI, in patients with asthma. Seventy-eight patients with asthma and 32 healthy control subjects were included. All individuals were tested using a triplestaining flow cytometry-based basophil activation test (BAT) for the potential presence of autoantibodies against FcεRI. Of the 78 asthma patients, 29 (37.2%) had a positive BAT result, indicating that their serum was able to activate basophils, compared with only four (12.5%) of the control group, a statistically significant between-group difference. These data suggest that some asthma patients have aberrant anti-FcεRI autoantibodies, which implies that autoimmunity may be one factor involved in the pathogenesis of intrinsic asthma.
Introduction
Asthma is a chronic inflammatory disorder of the airways which has a long history, even being described by Hippocrates. 1, 2 Traditionally, asthma has been regarded as a clinical manifestation of an allergic response to environmental agents, however considerable evidence now suggests that molecular defects in T helper (Th) lymphocyte-mediated immune regulation and multiple immune reactions contribute to the pathogenesis of asthma. 3 -7 The potential mechanisms other than atopy remain to be clarified. Allergy and autoimmune disease are two potential outcomes of dysregulated immunity; both are characterized by localized inflammation that leads to injury and/or destruction of target tissues. 8 Until recently, it was generally accepted that the mechanisms that govern these disease processes are quite disparate, however, new discoveries suggest a possible pathogenetic link between allergy and autoimmunity. 9 Basophil granulocytes and tissue mast cells and their mediators have been found to play a role in the pathogenesis of asthma. 10, 11 *RS Sun and JF Sui contributed equally to this article.
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Human basophils and mast cells (that are positive for the expression of the high-affinity receptor for immunoglobulin E [FcεRI + ]) can be activated through immunological interaction with the IgE-FcεRI network. 12, 13 Anti-IgE autoantibodies, although occasionally present in normal donors, more frequently occur in a variety of allergic diseases such as chronic urticaria, atopic dermatitis and bronchial asthma, as well as in autoimmune disorders such as rheumatoid arthritis, lupus erythematosus and systemic sclerosis. 14 The flow cytometry-based basophil activation test (BAT), based on the detection of allergen-induced CD63 and CD203c expression, has proved effective in the diagnosis of various IgE-mediated allergies. 15 The aim of the present study was to investigate basophil activation by the functional autoantibodies against FcεRI, as determined by the induction of CD63 expression using the flow cytometry-based BAT, in patients with asthma.
Patients and methods

PATIENTS
Subjects with a cough for more than 3 weeks and who exhibited one or more asthma symptoms and physical examinations compatible with the American Thoracic Society guidelines on the definition of asthma 16 were recruited randomly from the outpatient clinic of Guangzhou Institute of Respiratory Disease, Guangzhou, China, between October 2004 and February 2006. Healthy individuals awaiting elective eye surgery were recruited as controls. One nonallergenic adult, whose basophils were screened with antibody directed against FcεRI (Bülhmann Laboratories AG, Allschwill, Switzerland) for > 25% release, 17 was used to provide basophils for the BAT. All subjects gave informed consent and the study was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical College.
FLOW CYTOMETRY-BASED BAT
All tests were carried out within 4 h of collection of whole blood from the nonallergenic adult donor. The induction of CD63 expression was evaluated as follows. 18, 19 Sodium heparin-anticoagulated peripheral blood aliquots (100 µl) primed with 20 µl of interleukin (IL)-3 containing buffer (10 ng/ml, 10 min, 37°C) were stimulated at 37°C for 20 min with 100 µl of serum from either an asthma patient or a healthy control subject. The buffer comprised 0.12 M NaCI, 0.005 M KCI, 0.025 M Tris, pH 7.6. N-Formyl-methionyl-leucyl-phenylalanine (fMLP 0.4 mmol/l) (Sigma-Aldrich, St Louis, MO, USA), a non-specific cell activator, was used as a positive control and washing buffer (0.01 M phosphate buffered saline including 0.01 M NaH 2 PO 4 , 0.01 M Na 2 HPO 4 , pH 7.2 -7.4) was used as a negative control. After incubation, samples were cooled on ice to stop basophil activation and degranulation. The cells were mixed with staining reagents including fluorescein isothiocyanate (FITC)-conjugated anti-CD63 antibody (Becton Dickinson, Franklin Lakes, NJ, USA), phytoerythrin (PE)-conjugated anti-IgE antibody (Pharmacia, Uppsala, Sweden) and peridinin-chlorophyll-protein complex (PerCP)-conjugated anti-CD45 antibody (Becton Dickinson). After a 20-min incubation on ice in the dark, an erythrocyte lysing solution (Becton Dickinson) was used to lyse the erythrocytes and they were then washed in washing buffer and centrifuged for 10 min at 2500 rpm (desk-top centrifuge; Beckman Instruments, Palo Alto, CA, USA). The leucocyte pellets were resuspended in washing buffer and analysed by fluorescenceactivated cell sorting flow cytometry (FC500; Beckman Coulter, Fullerton, CA, USA).
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During acquisition, red fluorescence (FL2) and the forward scatter (FSC) and side scatter (SSC) characteristics were employed to gate at least 1000 basophils that expressed a high surface density of IgE. For analysis, a first gate using the FSC/SSC characteristics of lymphocytes was defined. Then, from these cells, basophils were selected as CD45 low/IgE high on an FL3/FL2 dot plot. Within this gate, the percentage of activated basophils, i.e. those co-expressing CD63 (FL1) was measured. For this purpose, quadrant markers were set on the value obtained without stimulation (negative control samples). Percentages of activated basophils were corrected by subtracting spontaneous CD63 expression (negative control) from the values obtained after stimulation with serum from individual patients and control subjects.
STATISTICAL ANALYSIS
Statistical evaluation was performed using the SPSS ® software program (SPSS Inc., Chicago, IL, USA). The χ 2 test was used to compare the patient and control groups. A Pvalue < 0.05 was considered significant.
Results
A total of 78 asthma patients and 32 healthy control subjects were included in the study.
MULTICOLOUR FLOW CYTOMETRY STRATEGY
The study used three-colour flow cytometric BAT protocols that relied on (i) the surface expression characteristics of basophils, i.e. low CD45 and high IgE expression, to identify the total basophil population, and (ii) on the monitoring of the basophil activation marker CD63 to determine the proportion of basophils that had been activated by exposure to patient and control serum. Triple-staining readily identified the total basophil population (high IgE) and localized them within the low CD45 region (Fig. 1) . Table 1 shows the number and proportion of patients and healthy control subjects with CD63 + basophils (autoantibodies against FcεRI) following serum challenge of whole blood from the non-allergenic adult donor. Using a cut-off of 8.1% of the level obtained following buffer challenge of whole blood from the non-allergenic adult, serum from 29/78 (37.2%) asthma patients showed CD63 + basophils and the mean ± SD proportion of the basophil population that was CD63 + was 36.9 ± 8.3%. In contrast, the serum from only 4/32 (12.5%) of the healthy control subjects showed CD63 + basophils and the mean ± SD proportion of the basophil population that was CD63 + was 26.3 ± 5.6%. The difference in the proportion of asthma patients versus the proportion of healthy control subjects having CD63 + basophils was statistically significant (P < 0.05).
CD63 EXPRESSION
No. (%) with CD63 + basophils χ 2 , P-value
Asthma patients (n = 78) 29 (37.2%) 5.46, P < 0.05 Healthy controls (n = 32) 4 (12.5%) 
Discussion
The present study provides further insight into the role of the high-affinity IgE receptor in the pathogenesis of asthma. Flow cytometry-based BAT showed that autoantibodies against FcεRI were observed in significantly more asthma patients than healthy controls (37.2% versus 12.5%, respectively), consistent with the results of our previous research 20 , which suggests that autoantibodies against FcεRI may be involved in the development of asthma. Asthma mechanisms, apart from atopy, in the development of airway responsiveness and inflammation remain to be clarified, however autoimmune disease has been implicated as a cause of intrinsic asthma. 21 The high-affinity IgE receptor, FcεRI, is a multimeric surface receptor that is expressed exclusively as a tetramer on rodent cells, but exists as a tetramer or trimer on human cells. 22 On mast cells and basophils, FcεRI is essential for IgE-mediated acute allergic reactions. 23 Cross-linking of the IgE-loaded FcεRI by multivalent antigens results in mast cell activation and subsequent release of multiple proinflammatory mediators. 24 Our research group has previously found anti-FcεRI autoantibodies in some urticaria patients. 17, 25 Considering this finding and that of the present study in asthma patients, allergy and autoimmunity might result from dysregulation of the immune system. The concomitant presentation of urticaria and asthma, and the potential relationship between them, such as the sharing of common pathogenic mechanisms, are revealed in some cases by looking at the key elements that regulate the immune response in both asthma and autoimmune disease, i.e. mast cells, antibodies, T cells, cytokines and genetic determinants. 26, 27 It has previously been suggested that autoantibodies against FcεRI or IgE may be involved in the pathogenesis of asthma. 28 -30 The present study's finding that significantly more asthma patients than healthy controls demonstrated positive autoantibodies against FcεRI supports the view that autoimmunity may be involved in the pathogenesis of asthma.
